Futura Medical plc (FAMDF)
- Previous Close
0.4300 - Open
0.5100 - Bid 0.5000 x --
- Ask 0.5500 x --
- Day's Range
0.5100 - 0.5500 - 52 Week Range
0.1500 - 0.6500 - Volume
33,424 - Avg. Volume
15,578 - Market Cap (intraday)
166.322M - Beta (5Y Monthly) 1.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Sep 10, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
www.futuramedical.comRecent News: FAMDF
View More
Performance Overview: FAMDF
Trailing total returns as of 10/29/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FAMDF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FAMDF
View MoreValuation Measures
Market Cap
151.44M
Enterprise Value
146.36M
Trailing P/E
--
Forward P/E
14.73
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
15.62
Price/Book (mrq)
16.43
Enterprise Value/Revenue
13.45
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-44.68%
Return on Assets (ttm)
-26.59%
Return on Equity (ttm)
-47.43%
Revenue (ttm)
8.4M
Net Income Avi to Common (ttm)
-3.75M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
3.92M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3M
Company Insights: FAMDF
FAMDF does not have Company Insights